Liu Hui
Fortune : - $ au 30/06/2026
Fortune : - $ au 30/06/2026
Liu Hui currently works at Rallybio Corp., as Independent Director from 2022.
Dr. Hui also formerly worked at Novartis AG, as VP & Head-Business Development & Licensing from 2013 to 2015 and Merus NV, as Chief Business Officer & Executive Vice President from 2015 to 2024.
Dr. Hui received his undergraduate degree from Peking University and Masters Business Admin degree and doctorate degree from the University of Michigan.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
RALLYBIO CORPORATION -.--% | 19/12/2025 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| RALLYBIO CORPORATION | Directeur/Membre du Conseil | 04/04/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| MERUS N.V. | Corporate Officer/Principal | 01/07/2024 |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2015 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merus NV
Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Rallybio Corp.
Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national